Assessment of a Simplified Format of Written Patient Prescription Drug Information

被引:5
|
作者
Papay, Julie I. [1 ]
Fritz, Deborah [2 ]
Cantu, Tom [3 ]
Ellis, Melissa [4 ]
Debussey, Sandy [5 ]
机构
[1] GlaxoSmithKline Inc, Global Clin Safety & Pharmacovigilance, Safety Evaluat & Risk Management, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline Inc, Healthcare Policy & Stand, US Pharmaceut, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline Inc, Global Regulatory Afffairs, Labeling, Upper Merion, PA USA
[4] GlaxoSmithKline Inc, Global Regulatory Afffairs, Labeling, Res Triangle Pk, NC 27709 USA
[5] GlaxoSmithKline Inc, Publ & Private Inst Customers, US Pharmaceut, Res Triangle Pk, NC 27709 USA
来源
DRUG INFORMATION JOURNAL | 2010年 / 44卷 / 04期
关键词
Consumer medication information; CMI; Prescription drug information; MEDICATION INSTRUCTIONS;
D O I
10.1177/009286151004400403
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Patients in the United States receive multiple forms of written information about their prescription medications. This pilot study was conducted to evaluate alternative formats of patient-directed written prescription information for four medications: cefaclor suspension, simvastatin tablets, albuterol inhaler, and capecitabine tablets. Fifty-four consumers evaluated this information using a 5-point satisfaction scale, responding to 10-12 questions, and participating in group discussion. Overall, consumers valued short, simple text, a question-answer format, a table layout, large font, adequate text spacing, bold type for emphasis, and easy-to-understand, actionable information that included impact statements on activities and lifestyle. This pilot study reveals that simplified prescription information with improved readability and reduced ambiguity may enhance consumer information retrieval and reinforce appropriate use of prescription medicines.
引用
收藏
页码:375 / 391
页数:17
相关论文
共 50 条